Differences between randomized clinical trial patients and real-world initiators of liraglutide

Jakob S. Knudsen, Reimar W. Thomsen, Anton Pottegård, Lisbeth M. Baggesen, Filip Knop, Henrik T. Sorensen

Research output: Contribution to journalConference abstract in journalResearchpeer-review

Original languageEnglish
JournalPharmacoepidemiology and Drug Safety
Volume27
Issue numberSuppl. 2
Pages (from-to)487
Number of pages1
ISSN1053-8569
Publication statusPublished - 1. Aug 2018
Event34th International Conference on Pharmacoepidemiology & Therapeutic Risk Management - Prag, Czech Republic
Duration: 21. Aug 201826. Aug 2018

Conference

Conference34th International Conference on Pharmacoepidemiology & Therapeutic Risk Management
CountryCzech Republic
CityPrag
Period21/08/201826/08/2018

Cite this

Knudsen, J. S., Thomsen, R. W., Pottegård, A., Baggesen, L. M., Knop, F., & Sorensen, H. T. (2018). Differences between randomized clinical trial patients and real-world initiators of liraglutide. Pharmacoepidemiology and Drug Safety, 27(Suppl. 2), 487.